Xiaofan Yang

Xiaofan Yang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Pharmacological Research
Verified
Journal Article
Closed access
XCXiaopei Cui
Xiaopei Cui
GPGuopin Pan
Guopin Pan
YCYe Chen
Ye Chen
XGXiaosun Guo
Xiaosun Guo
TLTengfei Liu
Tengfei Liu
FJFan Jiang
Fan Jiang

18 March 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
ZHZimeng He
Zimeng He
LZLinghui Zhu
Linghui Zhu
ZGZaifen Gao
Zaifen Gao
YLYumei Li
Yumei Li
XZXiaoyu Zhao
Xiaoyu Zhao
BLBaomin Li
Baomin Li
Aims: To predict the progression of children with self‐limited epilepsy with centrotemporal spikes (SeLECTS) to epileptic encephalopathy with spike‐and‐wave activation in sleep (EE‐SWAS).Methods: We conducted a retrospective analysis of early clinical and electroencephalography (EEG) data. Clinical parameters included demographic and epilepsy‐related characteristics. EEG were qualitatively (localization, lateralization, synchrony, non‐Rolandic discharges, nondipole spikes, multiple spikes, focal slow‐wave activity) and quantitatively (spike–wave index [SWI], spike–wave frequency [SWF], power spectral density [PSD], phase‐locking value [PLV], phase lag index [PLI], weighted phase lag index [wPLI], characteristic path length [CPL], clustering coefficient [CC], small‐worldness [Sigma]) analyzed. A logistic regression‐based prediction model was further formulated and evaluated.Results: This study included 50 children with seizure‐free typical SeLECTS and 76 who developed EE‐SWAS. Multivariable logistic regression revealed that early EEG features—SWF, relative PSD in the alpha band, wPLI and CPL in the delta band—were associated with the risk of encephalopathic transformation. The model demonstrated good performance with an area under the curve of 0.817 (95% confidence interval 0.736–0.898). The model showed a good fit and clinical benefit.Conclusion: Initial quantitative EEG characteristics of SeLECTS can predict the development of EE‐SWAS, suggesting distinct disease characteristics and pathogeneses in children at risk of encephalopathic transformation.

21 January 2024 in Epilepsy & Behavior
Verified
Journal Article
Closed access
XZXiaoyu Zhao
Xiaoyu Zhao
ZHZimeng He
Zimeng He
YLYumei Li
Yumei Li
XYXiaofan Yang
Xiaofan Yang
BLBaomin Li
Baomin Li

6 June 2022 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
YJYecheng Jin
Yecheng Jin
XGXiaotong Gao
Xiaotong Gao
MLMiaoqing Lu
Miaoqing Lu
GCGe Chen
Ge Chen
XYXiaofan Yang
Xiaofan Yang
JGJian gang Gao
Jian gang Gao
Mutations in genes encoding subunits of the BAF (BRG1/BRM-associated factor) complex cause various neurodevelopmental diseases. However, the underlying pathophysiology remains largely unknown. Here, we analyzed the function of Brahma-related gene 1 (Brg1), a core ATPase of BAF complexes, in the developing cerebral cortex. Loss of Brg1 causes several morphological defects resembling human malformations of cortical developments (MCDs), including microcephaly, cortical dysplasia, cobblestone lissencephaly and periventricular heterotopia. We demonstrated that neural progenitor cell renewal, neuronal differentiation, neuronal migration, apoptotic cell death, pial basement membrane and apical junctional complexes, which are associated with MCD formation, were impaired after Brg1 deletion. Furthermore, transcriptome profiling indicated that a large number of genes were deregulated. The deregulated genes were closely related to MCD formation, and most of these genes were bound by Brg1. Cumulatively, our study indicates an essential role of Brg1 in cortical development and provides a new possible pathogenesis underlying Brg1-based BAF complex-related neurodevelopmental disorders.

26 April 2023 in Frontiers in Neuroscience
Verified
Journal Article
Open access
YWYang Wang
Yang Wang
DZDongqing Zhang
Dongqing Zhang
LTLili Tong
Lili Tong
LYLu Yang
Lu Yang
PYPing Yin
Ping Yin
BLBaomin Li
Baomin Li
Background: Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis is infrequently reported but more and more recognizable in children. Here we give detailed description of the clinical features and long-term outcome of three cases of childhood onset anti-LGI1 encephalitis.Methods: Three anti-LGI1 encephalitis patients were hospitalized in the Department of Pediatrics at Qilu Hospital of Shandong University. Data about the clinical manifestations, treatments and long-term follow-up outcomes were described in detail.Results: Case 1 showed an adolescent girl with initiating symptom of acute-onset frequent focal seizures. Her serum LGI1-antibody test was positive, and she had a good response to antiseizure medication (ASM) and IVIG. Case 2 showed a preschool-age boy with long-period refractory focal seizures and recent behavioral change. Both serum and cerebrospinal fluid (CSF) tests of LGI1-antibody were positive, and the MRI showed progressive atrophy in the left hemisphere. The symptoms got improved after receiving second-line immunotherapy initially but there are still the sequelae of drug-resistant epilepsy and mild to moderate intellectual disability. Case 3 showed an adolescent boy with initiating symptom of acute-onset frequent focal seizures. Both serum and CSF tests of LGI1-antibody were positive, and he had a good response to immunotherapy. By analyzing all literature-reported 19 pediatric cases, we found pediatric anti-LGI1 encephalitis is more common in female and adolescent. Seizures and behavioral changes were the most common symptoms. CSF pleocytosis and LGI1-antibodies results were mostly negative. Most patients showed good response to immunotherapy.Conclusion: Childhood onset anti-LGI1 encephalitis is a heterogeneous clinical syndrome, ranging from typical limbic encephalitis to isolating focal seizures. It is important to test autoimmune antibodies when encountering similar cases and repeat antibody testing if necessary. Timely recognition leads to earlier diagnosis and more rapid initiation of effective immunotherapy and potentially better outcomes.

29 January 2021 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
PDF file
JLJingwei Liu
Jingwei Liu
KWKelai Wang
Kelai Wang
BLBaomin Li
Baomin Li
XYXiaofan Yang
Xiaofan Yang
Background: Congenital cervical spinal muscular atrophy (CCSMA) is a rare, nonprogressive, neurogenic disorder characterized by symmetric arthrogryposis and motor deficits mainly confined to upper extremities. Since its first proposal by Darwish et al. 39 years ago, only few cases have ever been reported. Vascular insult to the anterior horn of cervical spinal cord during fetal development was speculated to be the cause, however, the exact pathogenesis is still not well understood.Methods: In this study, whole‐exome sequencing (WES) and copy number variation (CNV) analysis were conducted on a definitive CCSMA patient, confirmed by the clinical manifestations and other supplementary examinations.Results: On physical examination, the patient was mainly characterized by symmetric, congenital, nonprogressive contractures, hypotonia, and muscle weakness mainly confined to the upper limbs, which were further supported by MRI and electromyography. Neuromuscular biopsy of the deltoid muscle demonstrated the type 1 myofiber predominance without any infiltration of inflammatory cells. The WES and CNV analysis unveiled a de novo Xp11.22–22.33 deletion. On further examination of the genes contained within this segment, we recognize UBA1 gene as the most likely pathogenic gene. Ubiquitin‐like modifier activating enzyme 1 is encoded by UBA1 gene (MIM 314370) located in Xp11.3 and is a critical protein that plays a vital role in ubiquitin‐proteasome system and autophagy. It is well documented that UBA1 gene mutation causes X‐linked infantile spinal muscular atrophy (XL‐SMA), which manifests phenotypes of arthrogryposis, hypotonia, and myopathic face. Type 2 XL‐SMA, which follows a nonprogressive and nonlethal course is very similar to the presentations of CCSMA.Conclusion: The phenotypic similarities between this CCSMA case and XL‐SMA prompt us to hypothesize a possible connection between UBA1 gene deficit and the pathogenesis of CCSMA. Our study is the first to demonstrate that CCSMA might have a genetic etiology, thus, expanding our insights into the underlying cause of CCSMA.